Pancreatic Cancer Research

ResearcherEast China University of Science and TechnologyNo recent work listed

Dan Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5586-4055; OpenAlex author ID A5100380747. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
28
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 2 papers · 2023: 2 papers

Papers 7

  1. Overexpression of ZNF488 supports pancreatic cancer cell proliferation and tumorigenesis through inhibition of ferroptosis via regulating SCD1-mediated unsatur… Co-author DOI 10.1186/s13062-023-00421-6↗
  2. MicroRNA 211-5p inhibits cancer cell proliferation and migration in pancreatic cancer by targeting BMP2. Co-author DOI 10.18632/aging.205320↗
  3. USP22-mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression. Co-author DOI 10.1002/1878-0261.13137↗
  4. Sequence-Activated Fluorescent Nanotheranostics for Real-Time Profiling Pancreatic Cancer. Co-author DOI 10.1021/jacsau.1c00553↗
  5. Construction of a novel bispecific fusion protein to enhance targeting for pancreatic cancer imaging. Co-author DOI 10.1016/j.biomaterials.2020.120161↗
  6. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation. Co-author DOI 10.1038/s41419-020-03019-2↗
  7. Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamyc… Co-author DOI 10.1016/j.acthis.2013.12.013↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chen Huan Luo · 1 shared paper, 2023 · strength 0.20
  2. Jianbing Wu · 1 shared paper, 2023 · strength 0.20
  3. Heshui Wu · 1 shared paper, 2022 · strength 0.20
  4. Xin Jin · 1 shared paper, 2022 · strength 0.20
  5. Dianyun Ren · 1 shared paper, 2022 · strength 0.20
  6. Shuisheng Zhang · 1 shared paper, 2023 · strength 0.17
  7. Qifeng Xiao · 1 shared paper, 2023 · strength 0.17
  8. Hu Ren · 1 shared paper, 2023 · strength 0.17
  9. Shunda Wang · 1 shared paper, 2023 · strength 0.17
  10. Jianwei Zhang · 1 shared paper, 2023 · strength 0.17
  11. Chengfeng Wang · 1 shared paper, 2023 · strength 0.17
  12. Hui Li · 1 shared paper, 2022 · strength 0.16
  13. Weihong Zhu · 1 shared paper, 2022 · strength 0.16
  14. Yingsheng Cheng · 1 shared paper, 2022 · strength 0.16
  15. Zhiqian Guo · 1 shared paper, 2022 · strength 0.16
  16. Yining Tao · 1 shared paper, 2022 · strength 0.16
  17. Dongnan Ping · 1 shared paper, 2020 · strength 0.12
  18. Guoping Ding · 1 shared paper, 2020 · strength 0.12
  19. Xiaodong Xu · 1 shared paper, 2020 · strength 0.12
  20. Shengnan Jia · 1 shared paper, 2020 · strength 0.12
  21. Liping Cao · 1 shared paper, 2020 · strength 0.12
  22. Xinming Zhao · 1 shared paper, 2020 · strength 0.11
  23. Kun Wang · 1 shared paper, 2020 · strength 0.11
  24. Zheng Li · 1 shared paper, 2020 · strength 0.11
  25. Qian Wang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.